Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism.
作者信息
Mathis J Michael, Stewart Phoebe L, Zhu Zheng B, Curiel David T
机构信息
Gene Therapy Program, Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
出版信息
Clin Cancer Res. 2006 May 1;12(9):2651-6. doi: 10.1158/1078-0432.CCR-06-0497.
Abstract
摘要
相似文献
1
Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism.新一代腺病毒病毒疗法药物基于不依赖CAR的嗜性体现出更高的效力。
Clin Cancer Res. 2006 May 1;12(9):2651-6. doi: 10.1158/1078-0432.CCR-06-0497.
2
Update on antiviral treatment of adenoviral ocular infections.腺病毒眼部感染的抗病毒治疗进展
Am J Ophthalmol. 2008 Nov;146(5):635-7. doi: 10.1016/j.ajo.2008.07.030.
3
Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient.一名小儿肝移植受者接受利巴韦林治疗后腺病毒性肝炎的清除情况。
Pediatr Infect Dis J. 2000 Nov;19(11):1097-100. doi: 10.1097/00006454-200011000-00016.
4
5-Fluorouracil-related enhancement of adenoviral infection is Coxsackievirus-adenovirus receptor independent and associated with morphological changes in lipid membranes.5-氟尿嘧啶相关的腺病毒感染增强与柯萨奇病毒-腺病毒受体无关，并与脂质膜的形态变化有关。
World J Gastroenterol. 2006 Aug 28;12(32):5168-74. doi: 10.3748/wjg.v12.i32.5168.
5
Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.将腺病毒感染重新靶向黑色素瘤：将天然嗜性的基因消融与结合纤维结和高分子量黑色素瘤相关抗原（HMWMAA）的重组双特异性单链双抗体（scDb）衔接子相结合。
Int J Cancer. 2004 Jan 1;108(1):136-45. doi: 10.1002/ijc.11563.
6
Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient.一名心脏移植患者的腺病毒肺炎采用更昔洛韦治疗。
Am J Med. 1997 Nov;103(5):439-40. doi: 10.1016/s0002-9343(97)85997-9.
7
[Oxoline in virus diseases of the conjunctivae and cornea].
Oftalmol Zh. 1969;24(6):451-3.
8
Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.柯萨奇病毒和腺病毒受体结合消融可降低腺病毒的肝脏嗜性和毒性。
Hum Gene Ther. 2005 Feb;16(2):248-61. doi: 10.1089/hum.2005.16.248.
9
[Study on chemotherapy of virus infections of the respiratory organs].[呼吸道器官病毒感染的化疗研究]
Nihon Ishikai Zasshi. 1967 May 1;57(9):1517-25.
10
Epidemic keratoconjunctivitis: a new approach.流行性角结膜炎：一种新方法。
Trans Am Acad Ophthalmol Otolaryngol. 1971 Nov-Dec;75(6):1216-22.
引用本文的文献
1
Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.第一章---癌症终结者病毒及其增强治疗效果的方法。
Adv Cancer Res. 2012;115:1-38. doi: 10.1016/B978-0-12-398342-8.00001-X.
2
Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.磁性纳米颗粒增强腺病毒在体外表征和体内转导。
Pharm Res. 2012 May;29(5):1203-18. doi: 10.1007/s11095-011-0629-9. Epub 2011 Dec 7.
3
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.利用血清型嵌合腺病毒（Ad.5/3）增强 mda-7/IL-24 的递送，联合 Apogossypol 衍生物 BI-97C1（Sabutoclax），可提高低 CAR 结直肠癌细胞的治疗效果。
J Cell Physiol. 2012 May;227(5):2145-53. doi: 10.1002/jcp.22947.
4
Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy.肿瘤血管靶向递呈聚合物连接的腺病毒载体用于癌症基因治疗。
Mol Ther. 2011 Sep;19(9):1619-25. doi: 10.1038/mt.2011.112. Epub 2011 Jun 14.
5
Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.使用嗜性修饰腺病毒载体增强基因向人原代内皮细胞的递送
Open Gene Ther J. 2008 Jan 1;1:7-11. doi: 10.2174/1875037000801010007.
6
Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.结肠癌中15-脂氧合酶-1的治疗性分子靶向作用
Mol Ther. 2008 May;16(5):886-92. doi: 10.1038/mt.2008.44. Epub 2008 Mar 18.
本文引用的文献
1
Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses.纤维嵌合溶瘤腺病毒增强对头颈部癌和黑色素瘤细胞的基因转移及溶瘤作用
Clin Cancer Res. 2006 May 1;12(9):2869-78. doi: 10.1158/1078-0432.CCR-05-2397.
2
Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling.通过基因衣壳标记对溶瘤腺病毒进行体内动态监测。
J Natl Cancer Inst. 2006 Feb 1;98(3):203-14. doi: 10.1093/jnci/djj022.
3
Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.采用肝组织切片分析来测定与复制型和非复制型腺病毒制剂相关的肝毒性。
Cancer Gene Ther. 2006 Jun;13(6):606-18. doi: 10.1038/sj.cgt.7700934.
4
The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35.膜辅因子蛋白CD46的远端短共有重复序列1和2及其与细胞膜的距离决定了B种35型腺病毒的有效进入。
J Virol. 2005 Aug;79(15):10013-22. doi: 10.1128/JVI.79.15.10013-10022.2005.
5
Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.将单纯疱疹病毒1型胸苷激酶基因整合到腺病毒蛋白IX中，以便在病毒粒子上进行功能展示。
Virology. 2005 Aug 1;338(2):247-58. doi: 10.1016/j.virol.2005.04.005.
6
7
CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells.靶向造血细胞的腺病毒载体在9埃分辨率下的冷冻电镜结构。
J Mol Biol. 2005 Jun 10;349(3):526-37. doi: 10.1016/j.jmb.2005.04.034.
8
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.感染性增强的、基于人端粒酶逆转录酶（hTERT）启动子的条件性复制腺病毒可用于小细胞肺癌（SCLC）的治疗。
Cancer Gene Ther. 2005 Sep;12(9):737-48. doi: 10.1038/sj.cgt.7700838.
9
10
Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.复杂镶嵌现象是一种增强基于5型腺病毒载体感染性的新方法。
Cancer Gene Ther. 2005 May;12(5):475-86. doi: 10.1038/sj.cgt.7700806.
Zotero 插件